DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	1 Months Ended						3 Months Ended		19 Months Ended
	Jun. 30, 2022	May 31, 2022	Feb. 28, 2022	Dec. 31, 2021	Nov. 30, 2021	May 31, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Jan. 31, 2022	Aug. 31, 2021
Warrants exercisable, exercisable number of warrants							81,072,855
Warrants issuance cost							$ 2,900,000
Common shares issued for cash								$ 51,805
Common stock, par value							$ 0.01		$ 0.01
Proceeds from sales of common stock								51,805
Net accumulated losses							26,139,062		$ 25,926,069
Working capital deficit							17,400,000
Net cash used in operating activities							251,017	962,668
First Fire Note [Member]
Conversion of stock, amount converted		$ 35,000
Conversion of stock, amount converted		500,000
November 2021 Note [Member]
Convertible notes into common stock, shares	4,025,000
Oncotelic Warrant [Member]
Number of shares of common stock			33,000,000
Warrants exercisable, exercisable number of warrants			50,000
Biomedical Advanced Research and Development Authority [Member]
Investment company, general partner advisory service							750,000
Supplemental Agreement [Member] | Golden Mountain Partners LLC [Member]
Investment company, grant amount							1,200,000
Equity Purchase Agreement [Member]
Number of shares of common stock									4,700,000
Proceeds from sales of common stock									$ 600,000
Equity Purchase Agreement [Member] | Peak One Opportunity Fund, L.P [Member]
Common shares issued for cash						$ 10,000,000.0
Common stock, par value						$ 0.01
Note Purchase Agreements [Member] | Autotelic Inc [Member]
Debt instrument face amount											$ 698,500
Debt instrumental interest rate											5.00%
Securities Purchase Agreements [Member]
Common stock, par value				$ 0.01	$ 0.01
Debt instrument face amount		$ 0.6		$ 0.25	$ 0.25			$ 0.25
Proceeds from convertible debt				$ 1,250,000	$ 1,250,000
Securities Purchase Agreement [Member]
Debt instrument face amount	$ 340,000
Securities Purchase Agreement And Purchase Agreement [Member] | Golden Mountain Partners [Member]
Debt instrument face amount										$ 4,500,000
Point R Merger Agreement [Member]
Working capital deficit							$ 2,600,000